These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31830250)

  • 21. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospitalizations of patients with herpes zoster in Poland during 2012-2021: A population-based study.
    Rząd M; Kanecki K; Lewtak K; Tyszko P; Gorynski P; Nitsch-Osuch A
    Vaccine; 2024 Mar; 42(8):1928-1933. PubMed ID: 38368221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
    Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
    J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based study.
    Studahl M; Petzold M; Cassel T
    BMC Infect Dis; 2013 Dec; 13():586. PubMed ID: 24330510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of herpes zoster amongst adults varies by severity of immunosuppression.
    Schröder C; Enders D; Schink T; Riedel O
    J Infect; 2017 Sep; 75(3):207-215. PubMed ID: 28676411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends in herpes zoster-related hospitalizations in Italy, 2001-2013: differences between regions that have or have not implemented varicella vaccination.
    Valente N; Cocchio S; Stefanati A; Baldovin T; Martinelli D; Prato R; Baldo V; Gabutti G
    Aging Clin Exp Res; 2017 Aug; 29(4):771-779. PubMed ID: 28608255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
    Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
    Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocompetent children account for the majority of complications in childhood herpes zoster.
    Grote V; von Kries R; Rosenfeld E; Belohradsky BH; Liese J
    J Infect Dis; 2007 Nov; 196(10):1455-8. PubMed ID: 18008223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.
    Schmidt SAJ; Vestergaard M; Baggesen LM; Pedersen L; Schønheyder HC; Sørensen HT
    Vaccine; 2017 Oct; 35(42):5589-5596. PubMed ID: 28874322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data.
    Forbes HJ; Bhaskaran K; Grint D; Hu VH; Langan SM; McDonald HI; Morton C; Smeeth L; Walker JL; Warren-Gash C
    Br J Dermatol; 2021 Jun; 184(6):1077-1084. PubMed ID: 33216946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014).
    García-Rojas A; Gil-Prieto R; Núñez-Gallo DÁ; Matute-Cruz P; Gil-de-Miguel A
    BMC Infect Dis; 2017 Aug; 17(1):586. PubMed ID: 28836951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of herpes zoster and chronic inflammatory skin disease in US inpatients.
    Chovatiya R; Silverberg JI
    J Am Acad Dermatol; 2021 Dec; 85(6):1437-1445. PubMed ID: 31958523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.
    Yanni EA; Ferreira G; Guennec M; El Hahi Y; El Ghachi A; Haguinet F; Espie E; Bianco V
    BMJ Open; 2018 Jun; 8(6):e020528. PubMed ID: 29880565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States.
    Meyers JL; Madhwani S; Rausch D; Candrilli SD; Krishnarajah G; Yan S
    Hum Vaccin Immunother; 2017 Aug; 13(8):1861-1872. PubMed ID: 28605285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term persistence of zoster vaccine efficacy.
    Morrison VA; Johnson GR; Schmader KE; Levin MJ; Zhang JH; Looney DJ; Betts R; Gelb L; Guatelli JC; Harbecke R; Pachucki C; Keay S; Menzies B; Griffin MR; Kauffman CA; Marques A; Toney J; Boardman K; Su SC; Li X; Chan IS; Parrino J; Annunziato P; Oxman MN;
    Clin Infect Dis; 2015 Mar; 60(6):900-9. PubMed ID: 25416754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
    Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination.
    Aziz M; Kessler H; Huhn G
    Int J STD AIDS; 2013 Jun; 24(6):433-9. PubMed ID: 23970744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008-2016.
    Cocchio S; Baldovin T; Furlan P; Bertoncello C; Buja A; Saia M; Fonzo M; Baldo V
    Aging Clin Exp Res; 2019 Jan; 31(1):145-150. PubMed ID: 29766448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability.
    Esteban-Vasallo MD; Domínguez-Berjón MF; Gil de Miguel Á; Astray-Mochales J; Blanco-Ancos LM; Gil-Prieto R
    J Infect; 2016 Jan; 72(1):70-9. PubMed ID: 26476152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
    Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
    Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.